Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Other Accumulated Expenses (2017 - 2025)

Updated

Niki BioSolutions (NIKI) posted Other Accumulated Expenses of $19,248 for FY2025.

Analysis

Niki BioSolutions (NIKI) Other Accumulated Expenses (2017 - 2025) Analysis & Trends

Since FY2017, Niki BioSolutions has reported Other Accumulated Expenses for 7 years.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -26.1% (FY2020 to FY2025).
  • The FY2025 figure stands as the highest annual Other Accumulated Expenses in data going back to FY2017.
  • Business Quant data shows NIKI's Other Accumulated Expenses at $310,548 in FY2022 (+113.6%) and $145,391 in FY2021 (+66.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Niki BioSolutions 2.51 Mn 2.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2025 19,248.00
Aug 31, 2025 12,154.00
May 31, 2025 5,884.00
Jun 30, 2023 305,055.00
Dec 31, 2022 310,548.00
Jun 30, 2022 339,649.00
Dec 31, 2021 145,391.00
Dec 31, 2020 87,378.00
Jun 30, 2020 419,875.00
Dec 31, 2019 118,846.00
Dec 31, 2018 90,451.00
Dec 31, 2017 38,496.00
API Access

Niki BioSolutions Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NIKI&period=max&api_key=YOUR_API_KEY